Clue operates a digital health platform focused on menstrual and reproductive health. Through its science-based period and cycle tracker, the company enables users to log symptoms, monitor patterns, and gain insights for better health choices. The app has surpassed 100 million downloads worldwide and is offered in 23 languages, underscoring its global resonance. Clue emphasizes stringent data-privacy standards and collaborates frequently with research institutions to ground its features in clinical evidence. Looking ahead, management plans to accelerate product innovation, broaden its geographic footprint, and deepen healthcare partnerships. The new capital will also fund further clinical research and technology development to deliver increasingly personalized care to users.

Total raised

$37M

Funding rounds

7

Latest round

Equity

Latest activity

Apr 2023